Astonea Labs Ltd

Astonea Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Astonea Labs Ltd

₹ 153 -2.52%
12 Dec - close price
astonea.org BSE - SME: 544409
About

Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies[1]

Key Points

Business Verticals[1]
a) Own brands: ** Its own brand include "Glow Up" (cosmetics) and "Regero" (pharmaceuticals).
b) Contract Manufacturing**: It also engages in contract manufacturing for domestic and international clients, serving markets like the USA, Bolivia, Guatemala, Botswana, Iraq, and Yemen.

Website BSE
  • Market Cap ₹ 161 Cr.
  • Current Price ₹ 153
  • High / Low ₹ 185 / 118
  • Stock P/E 34.7
  • Book Value ₹ 50.9
  • Dividend Yield 0.00 %
  • ROCE 17.3 %
  • ROE 35.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 30.4%

Cons

  • Stock is trading at 3.01 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE SME IPO

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2024 Sep 2025
47.27 66.29
40.69 60.92
Operating Profit 6.58 5.37
OPM % 13.92% 8.10%
0.09 0.10
Interest 1.75 1.54
Depreciation 2.13 2.15
Profit before tax 2.79 1.78
Tax % 23.66% 19.66%
2.13 1.42
EPS in Rs 2.76 1.35
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
30.04 66.89 80.06 97.38
24.21 59.75 68.14 82.09
Operating Profit 5.83 7.14 11.92 15.29
OPM % 19.41% 10.67% 14.89% 15.70%
0.12 0.21 0.10 0.19
Interest 1.58 2.34 2.97 3.83
Depreciation 3.79 3.93 3.67 4.58
Profit before tax 0.58 1.08 5.38 7.07
Tax % 56.90% 38.89% 24.35% 24.33%
0.25 0.67 4.07 5.35
EPS in Rs 0.62 1.68 5.36 6.93
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 48%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 178%
TTM: 31%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 30%
Last Year: 35%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 4.00 4.00 7.60 7.72 10.51
Reserves 3.49 4.16 4.26 10.69 42.96
29.53 35.99 42.39 53.33 39.05
15.89 20.13 26.47 31.64 29.30
Total Liabilities 52.91 64.28 80.72 103.38 121.82
21.39 20.75 21.75 25.03 26.08
CWIP 0.00 0.00 2.10 5.01 6.27
Investments 0.00 0.00 0.00 0.00 0.00
31.52 43.53 56.87 73.34 89.47
Total Assets 52.91 64.28 80.72 103.38 121.82

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-4.93 -1.05 7.86 9.25
-3.31 -3.08 -8.35 -11.14
8.17 4.14 -0.26 1.62
Net Cash Flow -0.07 0.01 -0.75 -0.27

Ratios

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 234.63 104.11 115.94 141.91
Inventory Days 136.35 121.40 160.81 160.68
Days Payable 273.08 128.11 148.90 143.66
Cash Conversion Cycle 97.89 97.41 127.85 158.93
Working Capital Days 98.30 32.79 28.22 29.31
ROCE % 8.01% 16.97% 17.30%

Shareholding Pattern

Numbers in percentages

5 Recently
Jun 2025Sep 2025
72.30% 72.30%
8.01% 2.51%
4.55% 0.35%
15.15% 24.84%
No. of Shareholders 1,014437

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP